MSA at NIH’s Countermeasures Against Chemical Threats (CounterACT) Symposium

June 14, 2017 

During the week beginning Sunday 6/11/17 Michael Mesa , President of Mesa Science Associates , will represent the company at the 11th Annual NIH CounterAct Research Symposium. This year’s event will be held in Boston Mass.  and will be hosted by Brigham and Women’s Hospital and The Harvard Medical School Center for CounterAct Excellence. For the 6th year Mr. Mesa will join clients and colleagues from around the world for this important medical/pharmaceutical  conference. This years’ event includes a special treat which is  a dinner at John F. Kennedy Presidential Library and Museum.

MSA News

Internship Experience Reflection – Kaitlyn Wylie

I never thought my first job would be in the biotechnology and pharmacy industry, let alone with such a passionate…

Read More

MesaGreen Pharmaceutical Company Files an Investigational New Animal Drug Application

FREDERICK, MD.  Nov. 10, 2022—MesaGreen Pharmaceutical Company announced today that the company has filed an Investigational New Animal Drug (INAD)…

Read More

Mesa Science Associates Receives Grant to Begin Study of a Treatment for Marfan Syndrome

Mesa Science Associates Inc. (MSA) received a Phase I Small Business Innovative Research Grant (SBIR) from the National Institutes of…

Read More